Autopsy report · NCT02950649

Evaluation of Clinical Impact of Non-Invasive Hemodynamic Monitoring to Optimize Perioperative Care

“PI left institution 10/01/2020 and no further subjects were enrolled and no further data was collected.”

The sponsor’s own words in the registry.

Life of this trial

• Registered 3 months before it started.
• Ran for about 4 years 7 months before it stopped.
• 189 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Sponsor

Loma Linda University

Sponsor type

University, hospital or other

Conditions

Hemodynamic Monitoring

Interventions

invasive Hemodynamic monitoring via Clearsight/Nexfin Systems from Edwards Lifesciences; No Hemodynamic Monitored Guided Assesment

Participants

189

Sites

3

Countries

United States

Trials that died the same way

• Transcranial Stimulation During Sleep to Improve Cognition in Epilepsy
  “PI left institution and no subjects enrolled.” (88% match in meaning)
• Divalproex Sodium in the Treatment of the Cutaneous Manifestations of Scleroderma
  “No subjects were enrolled.” (78% match in meaning)
• Vaccine Response With NT-I7
  “No subjects enrolled.” (77% match in meaning)
• Activated T-cell Therapy, Low-Dose Aldesleukin, and Sargramostim in Treating Patients With Ovarian, Fallopian Tube, or Primary Peritoneal Cancer That is Stage III-IV, Refractory, or Recurrent
  “Study did not accrue any participants, the PI has left the institution.” (77% match in meaning)
• Phrenic Nerve Stimulation for Treatment of Central Sleep Apnea
  “No eligible subjects were identified.” (75% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.